UA105827C2 - Терапевтична комбінація теоброміну і антигістаміну, який діє на н1-рецептор - Google Patents

Терапевтична комбінація теоброміну і антигістаміну, який діє на н1-рецептор

Info

Publication number
UA105827C2
UA105827C2 UAA201208623A UAA201208623A UA105827C2 UA 105827 C2 UA105827 C2 UA 105827C2 UA A201208623 A UAA201208623 A UA A201208623A UA A201208623 A UAA201208623 A UA A201208623A UA 105827 C2 UA105827 C2 UA 105827C2
Authority
UA
Ukraine
Prior art keywords
heading
antihistamine
theobromine
herapeutic
receptor
Prior art date
Application number
UAA201208623A
Other languages
English (en)
Russian (ru)
Inventor
Джон Брю
Робін Марк Банністер
Original Assignee
Байокоупі Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байокоупі Лімітед filed Critical Байокоупі Лімітед
Publication of UA105827C2 publication Critical patent/UA105827C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Винахід стосується засобу, що включає теобромін і антигістамін, який діє на H-рецептор, у вигляді комбінованого препарату для лікування кашлю.
UAA201208623A 2009-12-14 2010-12-14 Терапевтична комбінація теоброміну і антигістаміну, який діє на н1-рецептор UA105827C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
PCT/GB2010/052086 WO2011073647A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Publications (1)

Publication Number Publication Date
UA105827C2 true UA105827C2 (uk) 2014-06-25

Family

ID=41667043

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201208623A UA105827C2 (uk) 2009-12-14 2010-12-14 Терапевтична комбінація теоброміну і антигістаміну, який діє на н1-рецептор

Country Status (17)

Country Link
EP (1) EP2512472A1 (uk)
JP (2) JP2013513652A (uk)
CN (1) CN102802625A (uk)
AU (1) AU2010332495C1 (uk)
BR (1) BR112012014159A8 (uk)
CA (1) CA2784215A1 (uk)
CO (1) CO6541638A2 (uk)
GB (1) GB0921803D0 (uk)
IL (1) IL220384A0 (uk)
MX (1) MX2012006624A (uk)
NZ (1) NZ600267A (uk)
PE (1) PE20121538A1 (uk)
RU (1) RU2012129675A (uk)
SG (2) SG181603A1 (uk)
UA (1) UA105827C2 (uk)
WO (1) WO2011073647A1 (uk)
ZA (1) ZA201204294B (uk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
CN103263533B (zh) * 2013-05-31 2014-11-05 杨宏伟 一种治疗咳嗽的可可碱组合物及其用途及其制剂
CN104224819B (zh) * 2014-09-18 2016-08-17 中山大学 一种柚皮苷与盐酸左西替利嗪药物组合物及其制剂
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247709B1 (en) * 1986-04-17 1991-01-02 Alza Corporation Chlorpheniramine therapy
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
JPH10316568A (ja) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003012514A (ja) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003128549A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
WO2008127975A2 (en) * 2007-04-11 2008-10-23 Alcon Research, Ltd. Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis

Also Published As

Publication number Publication date
ZA201204294B (en) 2013-02-27
CA2784215A1 (en) 2011-06-23
PE20121538A1 (es) 2012-12-21
GB0921803D0 (en) 2010-01-27
IL220384A0 (en) 2012-08-30
AU2010332495B2 (en) 2015-01-22
JP2016040280A (ja) 2016-03-24
WO2011073647A1 (en) 2011-06-23
MX2012006624A (es) 2012-10-05
AU2010332495A1 (en) 2012-06-21
NZ600267A (en) 2013-07-26
BR112012014159A8 (pt) 2017-12-26
CO6541638A2 (es) 2012-10-16
JP6078605B2 (ja) 2017-02-08
BR112012014159A2 (pt) 2017-08-29
CN102802625A (zh) 2012-11-28
RU2012129675A (ru) 2014-01-27
AU2010332495C1 (en) 2016-02-11
SG10201408374WA (en) 2015-01-29
JP2013513652A (ja) 2013-04-22
SG181603A1 (en) 2012-07-30
EP2512472A1 (en) 2012-10-24

Similar Documents

Publication Publication Date Title
UA105827C2 (uk) Терапевтична комбінація теоброміну і антигістаміну, який діє на н1-рецептор
NZ619520A (en) Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
UA96124C2 (uk) Фармацевтичний пінний склад, який включає іміквімод
AP2507A (en) Quinoline derivatives and use thereof as mycobacterial inhibitors.
PL2679676T3 (pl) Sposoby i organizmy do sprzężonego ze wzrostem wytwarzania 1,4-butanodiolu
IL180872A0 (en) Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv
TNSN08178A1 (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
UA93903C2 (uk) Похідні тетрагідроізохіноліну для підвищення функції пам'яті
MX362442B (es) Inhibidores de enzima 1 dependiente de inositol (ire-1alfa).
MY148723A (en) Use of pinolenic acid for the treatment of obesity
WO2008089397A3 (en) Adrb2 cancer markers
MX343598B (es) Teobromina en combinacion con un expectorante o un mucolitico para uso en terapia.
TW200631584A (en) A medicament related to mirtazapine for the treatment of hot flush
PL2410047T3 (pl) Oksydoreduktaza i jej zastosowanie do redukcji sekodionu
WO2009149058A3 (en) Modified release niacin formulations
WO2011058373A3 (en) Drug combination with theobromine and its use in therapy
MX343222B (es) Combinacion de teobrina con un descongestionante y su uso para el tratamiento de la tos.
AU321418S (en) Restraint device
WO2012054093A3 (en) Acyl piperidine inhibitors of soluble epoxide hydrolase
UA105940C2 (uk) Лікарська комбінація з теоброміном та опіатом і її використання в лікуванні кашлю
WO2010120817A3 (en) Nanochanneled device and related methods
GB201219334D0 (en) Catheter having inflation and deflation lumen useful for preventing or reducing reperfusion injury
MX2012005849A (es) Compuestos inmunomoduladores para la restauracion de la sensibilidad a vitamina d en celulas tumorales resistentes a vitamina d.
TW200635934A (en) Amorphous tacrolimus and preparation thereof
WO2012040444A3 (en) Treatment of patients with incipient alzheimer's disease